National Institute of Child Health, Hungary Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2014
NCT01995721
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Papilloma (Phase 3)

Papillomavirus Infections (Phase 3)

Respiratory Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1